Product Details

// Quality First, Safety Guaranteed.

Mazutide

Peptides

fusiyao888@outlook.com
tel:+85244724547
Contact us via WhatsApp

Basic Info.

Mazutide is a dual agonist of the GLP-1receptor and glucagon receptor. It is an analog of oxyntomodulin (OXM).

The drug is developed by Eli Lilly and is currently in multiple Phase III studies.

In May 2025, a result of Phase III study has shown that once-weekly mazutide led to clinically relevant reductions in body weight in Chinese adults with overweight or obesity.

Areas of Expertise

Leading-Edge Manufacturing Capabilityg
Advanced R&D and State-of-the-Art Facilities
Versatile and Scalable Packaging Solutions
Certified Quality & International Compliance

< Previous

Cagrilintide

Next >

NAD

Leave a message

Happy to answer all your questions.